Status and phase
Conditions
Treatments
About
Subjects will perform experiments in an at home-setting. The effect of caffeine in coffee will be tested in subjects with computer tests on attention and alertness. Comparison of the results with published results from controlled experiments will indicate the effectiveness of home experiments.
Full description
There is increasing interest in the general public in measuring health parameters at home, instead of in a medical setting. Many tests for measuring health parameters are commonly available in drug stores as well as online. When structured, this trend may also be used for performing a randomized intervention trial.
The current study is aimed to evaluate the procedure of performing a non invasive intervention study by subjects themselves performing the tests at home.
The study is designed as a randomized, placebo-controlled, double blind, crossover study.
Subjects have to consume a cup of coffee after an overnight fast. Coffee will be prepared from instant coffee containing either regular coffee or decaff coffee. Each intervention will be given twice.
Effects on alertness and attention will be established by three computerized tests provided by Quantified Mind. The tests will be performed by the subjects at t=0 (baseline, prior to coffee consumption) and t=1h, one hour after coffee consumption, in one go. Each test will be performed during 5 minutes. During the training session the participants will be instructed to get acquainted with the task.
The evaluation of the study concerns the effect of caffeine in the at home setting versus published results, as well as reproducibility of the results.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Healthy as assessed by the:
Adult age (>18y)
Able to perform computerized tests
Voluntary participation
Having given written informed consent
Willing to comply with the study procedures
Moderate caffeine users
Able to use a desk top or laptop with internet access at home
Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data 10 Willing to accept the disclosure of the financial benefit of participation in the study to the authorities concerned
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
70 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal